CLINICAL_TRIALS trial_result · 2020-10-26

Clinical Trial Update: A Repeated Study of KRN23 in Adults With X-Linked Hypophosphatemia [Phase 1, Phase 2]

A Phase 1/Phase 2 study of KRN23 in adults with X-linked hypophosphatemia has completed, and results were posted in 2020.

Upgrade for the full analysis, importance score, and drug timeline.

Sponsor: Kyowa Kirin Co., Ltd. | Conditions: X-linked Hypophosphatemia | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2020-10-26